- Home
- ERAS vs IFN Comparison
ERAS vs IFN Comparison
Compare ERAS & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- IFN
- Stock Information
- Founded
- ERAS 2018
- IFN 1993
- Country
- ERAS United States
- IFN Singapore
- Employees
- ERAS N/A
- IFN N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- IFN Finance/Investors Services
- Sector
- ERAS Health Care
- IFN Finance
- Exchange
- ERAS Nasdaq
- IFN Nasdaq
- Market Cap
- ERAS 719.0M
- IFN 666.1M
- IPO Year
- ERAS 2021
- IFN N/A
- Fundamental
- Price
- ERAS $2.67
- IFN $17.37
- Analyst Decision
- ERAS Strong Buy
- IFN
- Analyst Count
- ERAS 5
- IFN 0
- Target Price
- ERAS $6.10
- IFN N/A
- AVG Volume (30 Days)
- ERAS 1.7M
- IFN 135.2K
- Earning Date
- ERAS 11-12-2024
- IFN 01-01-0001
- Dividend Yield
- ERAS N/A
- IFN 8.68%
- EPS Growth
- ERAS N/A
- IFN N/A
- EPS
- ERAS N/A
- IFN N/A
- Revenue
- ERAS N/A
- IFN N/A
- Revenue This Year
- ERAS N/A
- IFN N/A
- Revenue Next Year
- ERAS N/A
- IFN N/A
- P/E Ratio
- ERAS N/A
- IFN N/A
- Revenue Growth
- ERAS N/A
- IFN N/A
- 52 Week Low
- ERAS $1.51
- IFN $14.40
- 52 Week High
- ERAS $3.45
- IFN $21.25
- Technical
- Relative Strength Index (RSI)
- ERAS 43.56
- IFN 36.18
- Support Level
- ERAS $2.59
- IFN $17.13
- Resistance Level
- ERAS $3.19
- IFN $18.03
- Average True Range (ATR)
- ERAS 0.20
- IFN 0.23
- MACD
- ERAS -0.02
- IFN -0.03
- Stochastic Oscillator
- ERAS 20.13
- IFN 26.11
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About IFN India Fund Inc. (The)
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing primarily in the equity securities of Indian companies. The company's portfolio is non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities and others. Geographically, all the business activity functions through the market of United States.